Funding Details
- Awarder
- WeFunder
- Date Award
- June 12, 2024
- Vertical
- Healthcare
- Funding URL
- View Funding Page
Company Info
- Founders
- Jim Iversen
- Company Description
- Sen-Jam Pharmaceutical is revolutionizing hangover relief with their groundbreaking hangover prevention product, SJP-001. With over 2 billion people worldwide consuming alcohol and a projected $4.69 billion global hangover cure market by 2028, SJP-001 aims to be the first FDA-approved product in this space. Sen-Jam Pharmaceutical is focused on setting a new standard in the hangover prevention market by leveraging scientific research and evidence-based solutions.
- Market
- Hangover Prevention
- Location
-
US
Links